Literature DB >> 6768151

Preparation of a viable population of indium-111-labelled human blood platelets.

A D Heyns, P N Badenhorst, H Pieters, M G Lötter, P C Minnaar, L J Duyvené de Wit, O R Van Reenen, F P Retief.   

Abstract

Factors influencing labelling of human platelets with 111Indium-8-hydroxyquinoline ([111In]-oxine) in a physiological saline medium were investigated. The efficiency of labelling is influenced by time of incubation, concentration of oxine, and pH of the incubating medium. It was found that a viable platelet population could be labelled under the following conditions: (1) centrifugation of platelet rich plasma in polystyrene conical tubes at 800 g for 15 min; (2) resuspension of the platelet pellet in saline, pH 5.5; (3) incubating for 30 min at 22 degrees C with [111In]-oxine at a concentration of 6.25 mg oxine/litre platelet suspension; (4) washing once with platelet poor autologous plasma (PPP); and (5) finally resuspending the platelets in PPP. The labelled platelets aggregated normally with collagen and ADP. Electron microscopy, done immediately after labelling, showed internal organelle reorganization characteristic of activated platelets. These ultrastructural features were reversible on incubation in PPP at 37 degrees C for 30 min. The 111In is not released from aggregated platelets and the label does not elute from incubated platelets for at least five hr. We conclude that human platelets thus labelled are suitable for in vivo kinetic studies.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6768151

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  9 in total

1.  Scanning laser ophthalmoscope imaging of fluorescein-labelled blood cells.

Authors:  J F Le Gargasson; M Paques; J E Guez; B Boval; E Vicaut; X Hou; Y Grall; A Gaudric
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-01       Impact factor: 3.117

2.  An improved method for the quantification of the in vivo kinetics of a representative population of 111In-labelled human platelets.

Authors:  P Wessels; A D Heyns; H Pieters; M G Lötter; P N Badenhorst
Journal:  Eur J Nucl Med       Date:  1985

3.  111In-tropolonate labelled platelets; studies in normals and in patients with thrombocytopenia.

Authors:  H Louwes; H Beekhuis; W T Goedemans; S P Keijser; J J Schuurman
Journal:  Eur J Nucl Med       Date:  1987

4.  A simple and safe technique for sterile autologous platelet labelling using "Monovette" vials.

Authors:  H Sinzinger; H Kolbe; E Strobl-Jäger; R Höfer
Journal:  Eur J Nucl Med       Date:  1984

5.  Functional alterations of human platelets following indium-111 labelling using different incubation media and labelling agents.

Authors:  Y Isaka; K Kimura; M Matsumoto; T Kamada; M Imaizumi
Journal:  Eur J Nucl Med       Date:  1991

6.  Platelet accumulation on an artificial surface in vivo: effect of intravascular hemolysis.

Authors:  F G McCord; D R Gross
Journal:  Tex Heart Inst J       Date:  1987-06

7.  Platelet survival determined with 51Cr versus 111In.

Authors:  V Kiefel; T Becker; G Mueller-Eckhardt; S Grebe; C Mueller-Eckhardt
Journal:  Klin Wochenschr       Date:  1985-01-15

8.  Quantification of the distribution of 111In-labelled platelets in organs.

Authors:  P C van Reenen; M G Lötter; A D Heyns; F de Kock; C Herbst; H Kotzé; H Pieters; P C Minnaar; P N Badenhorst
Journal:  Eur J Nucl Med       Date:  1982

9.  Role of factor VIII-von Willebrand factor and fibronectin in the interaction of platelets in flowing blood with monomeric and fibrillar human collagen types I and III.

Authors:  W P Houdijk; K S Sakariassen; P F Nievelstein; J J Sixma
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.